ClaripulseClaripulse
MAUDE LookupResourcesBlog
LoginGet Early Access
ClaripulseClaripulse

Product

MAUDE LookupDashboard

Guides

FDA MAUDE DatabasePost-Market SurveillanceSignal Detection

Learn

BlogResourcesWhy Claripulse?

Legal

Privacy PolicyTerms of Service

This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified — do not attempt re-identification. © 2026 Claripulse.

Back to Cardiac Rhythm Management
MAUDE LookupCardiac Rhythm ManagementVIGILANT X4 CRT-D

VIGILANT X4 CRT-D Adverse Events: FDA MAUDE Data

BOSTON SCIENTIFIC CORPORATION · CRT-Defibrillator (CRT-D) · First cleared May 2002

Total Reports

2,154

Reports (30d)

63

Active Signals

2

Open Recalls

1

Monthly Report Volume
Event Type Breakdown

What the reports describe · Claripulse analysis

Most commonly reported problems

1

Inappropriate Therapy Delivered for Atrial Rhythm

crt, remains service, therapy, tachycardia, delivered

18

reports

2

High Out-of-Range Shock Impedance Measurements

measurements, crt, shock, impedance, range

18

reports

3

CRT Revision Due to Infection

crt, crt revision, infection additional, reported crt, revision infection

15

reports

4

Battery Voltage Low, Data Analysis Requested

crt, battery, effects, data, voltage

9

reports

5

CRT Revision for Infection

crt revision, infection additional, reported crt, revision infection, crt explanted

8

reports

6

Noise and Oversensing on Atrial Channel

defibrillator crt, crt, effects, service, therapy defibrillator

8

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Detection

Active safety signals

Disproportionate reportinghighIncreasing trendcritical

Regulatory

FDA recalls for this device

Class II

Jul 7, 2022 · Open, Classified

There is potential for unanticipated software anomalies to occur when using the Model 2868 Application loaded on the 3120 ZOOM LATITUTDE programmer when communicating with certain Boston Scientific transvenous defibrillators.

Evidence

Related research

Impact of wideband phase-sensitive inversion recovery motion corrected late gadolinium imaging on 3T cardiac magnetic resonance image quality and diagnostic utility in patients with cardiac implantable electronic devices.

Black C, et al. · 2025

Citations indexed from PubMed.

Keep exploring

Related devices in CRM

CAPSUREFIX Novus

MEDTRONIC, INC. · 43,528 reports

→

EMBLEM S-ICD

BOSTON SCIENTIFIC CORPORATION · 36,855 reports

→

Sprint Quattro Secure S MRI SureScan

MEDTRONIC, INC. · 36,335 reports

→

CapSureFix Novus MRI SureScan

MEDTRONIC, INC. · 27,017 reports

→

Durata

ABBOTT (ST. JUDE MEDICAL) · 19,619 reports

→

Quadra Assura MP

ABBOTT (ST. JUDE MEDICAL) · 10,450 reports

→

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 2 active signals detected right now.

Get Early Access

Understanding this data

What FDA MAUDE data does and does not tell you

How these reports are filed, why raw counts mislead, and the limits to know before drawing conclusions.

→

How a safety signal is detected

What the "Active Signals" count above means and the methods that separate a real signal from noise.

→
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.